Androgen up-regulated VEGF in CWR22 human prostate cancer model

被引：0
|
作者：
Zhang, S [1 ]
Dominguez, J [1 ]
Eble, JN [1 ]
Cheng, L [1 ]
机构：
[1] Indiana Univ, Sch Med, Indianapolis, IN USA
来源：
LABORATORY INVESTIGATION | 2002年 / 82卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
788
引用
收藏
页码：188A / 189A
页数：2
相关论文
共 50 条
  • [1] Androgen up-regulated VEGF in CWR22 human prostate cancer model
    Zhang, S
    Dominguez, J
    Eble, JN
    Cheng, L
    MODERN PATHOLOGY, 2002, 15 (01) : 188A - 189A
  • [2] Androgen-Regulated and Highly Tumorigenic Human Prostate Cancer Cell Line Established from a Transplantable Primary CWR22 Tumor
    Dagvadorj, Ayush
    Tan, Shyh-Han
    Liao, Zhiyong
    Cavalli, Luciane R.
    Haddad, Bassem R.
    Nevalainen, Marja T.
    CLINICAL CANCER RESEARCH, 2008, 14 (19) : 6062 - 6072
  • [3] CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy
    Cheng, L
    Sun, J
    Pretlow, TG
    Culp, J
    Yang, NS
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (09) : 607 - 611
  • [4] Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells
    Tan, J
    Sharief, Y
    Hamil, KG
    Gregory, CW
    Zang, DY
    Sar, M
    Gumerlock, PH
    White, RWD
    Pretlow, TG
    Harris, SE
    Wilson, EM
    Mohler, JL
    French, FS
    MOLECULAR ENDOCRINOLOGY, 1997, 11 (04) : 450 - 459
  • [5] Ligand responsiveness in human prostate cancer: Structural analysis of mutant androgen receptors from LNCaP and CWR22 tumors
    McDonald, S
    Brive, L
    Agus, DB
    Scher, HI
    Ely, KR
    CANCER RESEARCH, 2000, 60 (09) : 2317 - 2322
  • [6] Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line
    Tepper, CG
    Boucher, DL
    Ryan, PE
    Ma, AH
    Xia, LA
    Lee, LF
    Pretlow, TG
    Kung, HJ
    CANCER RESEARCH, 2002, 62 (22) : 6606 - 6614
  • [7] Apoptosis levels increase after castration in the CWR22 human prostate cancer xenograft
    Smitherman, AB
    Gregory, CW
    Mohler, JL
    PROSTATE, 2003, 57 (01): : 24 - 31
  • [8] Src controls castration recurrence of CWR22 prostate cancer xenografts
    Su, Bing
    Gillard, Bryan
    Gao, Lingqiu
    Eng, Kevin H.
    Gelman, Irwin H.
    CANCER MEDICINE, 2013, 2 (06): : 784 - 792
  • [9] Metastatic phenotype in CWR22 prostate cancer xenograft following castration
    Seedhouse, Steven J.
    Affronti, Hayley C.
    Karasik, Ellen
    Gillard, Bryan M.
    Azabdaftari, Gissou
    Smiraglia, Dominic J.
    Foster, Barbara A.
    PROSTATE, 2016, 76 (04): : 359 - 368
  • [10] Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells
    Yuan, Xin
    Li, Tong
    Wang, Hongyun
    Zhang, Tao
    Barua, Moumita
    Borgesi, Robert A.
    Bubley, Glenn J.
    Lu, Michael L.
    Balk, Steven P.
    AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (02): : 682 - 696
12345